Boiron Stock

Boiron FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Boiron (BOI.PA) as of Aug 13, 2026 is 91.04 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 274.65 % — a change of -66.85% (lower).

FCF Conversion

91.04 %

YoY

-66.85%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Boiron is 2026 91.04 % . FCF Conversion Rate (FCF/EBITDA) of Boiron was 2025 274.65 % . It decreases by -66.85% lower compared to the previous year.
Access this data via the Eulerpool API

Boiron Stock analysis

What does Boiron do? Boiron SA is a French company specializing in the production of homeopathic medicines. It was founded in 1932 by the brothers Jean and Henri Boiron and has its headquarters in Lyon, France. Boiron SA is now a global leader in the production of medicines based on natural ingredients. Boiron is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Boiron stock

FCF Conversion Rate (FCF/EBITDA) of Boiron is 91.04 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Boiron changed from 274.65 % to 91.04 %, representing a -66.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Boiron since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Boiron with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Boiron

All Key Metrics — Boiron